Welcome to MediPocket USA, where we redefine healthcare accessibility through innovation and compassion. Our mission is to bridge the gap between international patients and top-tier medical care in the United States, ensuring that everyone, regardless of geographical boundaries, can access world-class healthcare.
Our Vision
We envision a world where advanced medical treatments and expertise are within reach for everyone. By leveraging digital platforms, we connect patients from around the globe with leading healthcare providers in the United States, offering a seamless, comprehensive, and patient-centric experience.
Our Services
Virtual Consultations: We facilitate telemedicine consultations with top US specialists, allowing patients to receive expert medical opinions and personalized treatment plans from the comfort of their homes.
Medical Coordination: From scheduling appointments to arranging travel and accommodation, we handle all logistics, ensuring a hassle-free process for our patients.
Clinical Trials: We provide access to cutting-edge clinical trials, enabling patients to benefit from the latest medical advancements and innovative treatments.
Learn More: www.medipocketusa.com
Book USA Consultation: https://medipocketusa.com/contact-us/
Email your inquiry: health@mymedipocket.com
Follow On:
Instagram - https://www.instagram.com/medipocket/
Facebook - https://www.facebook.com/MediPocket
Twitter - https://twitter.com/mediPocket2
0
Total investors
0
Early stage
0
Mid stage
0
Late stage
—
Founded
Investors
0 investors
All
Early stage
Mid stage
Late stage
No investors in this category
Frequently asked questions
What industry is MediPocket USA - Cross Border Care in?
MediPocket USA - Cross Border Care operates in Hospitals and Health Care. Find similar Hospitals and Health Care investors on gritt.io.
Where is MediPocket USA - Cross Border Care based?
MediPocket USA - Cross Border Care is headquartered in Los Angeles, United States.
Find investors for your startup like MediPocket USA - Cross Border Care
Gritt sends AI-personalised outreach to each investor — from your Gmail
